Abstract:The serine/threonine kinase, Akt (protein kinase B) plays a central role in the regulation of intracellular cell survival. Recently, we demonstrated that the proto-oncogene TCL1, overexpressed in human T-cell prolymphocytic leukemia, is an Akt kinase co-activator. Tightly restricted TCL1 gene expression in early developmental cells suggested that the TCL1 gene is regulated at a transcriptional level. To characterize how TCL1 gene expression is regulated, we cloned the 5'-promoter of the TCL1 gene located at human chromosome 14q32. The 5'-TCL1 promoter region contains a TATA box with cis-regulatory elements for Nur77/NGFI-B (nerve growth factor-responsive element (NBRE), CCAAGGTCA), NFkappaB, and fork head transcription factor. Nur77/NGFI-B, an orphan receptor superfamily transcription factor implicated in T-cell apoptosis, is a substrate for Akt. We hypothesized that TCL1 transactivity is regulated through Akt-induced phosphorylation of Nur77/NGFI-B in vivo. In an electrophoretic mobility shift assay with chromosomal immunoprecipitation assays, wild-type Nur77, but not S350A mutant Nur77, could specifically bind to TCL1-NBRE. A luciferase assay demonstrated that TCL1-NBRE is required for inhibition of TCL1 transactivity upon nerve growth factor/platelet-derived growth factor stimulation, which activates Akt and phosphorylates Nur77. Using a chromosomal immunoprecipitation assay with reverse transcription-PCR, nerve growth factor stimulation inhibited binding of endogenous Nur77 to TCL1-NBRE, in turn, suppressing TCL1 gene expression. The results together establish that TCL1-NBRE is a novel negative regulatory element of Nur77 (NGFI-B). To the best of our knowledge, TCL1-NBRE is the first direct target of Nur77 involving the regulation of intracellular cell death survival. This Akt-induced inhibitory mechanism of TCL1 should play an important role in immunological and/or neuronal development in vivo.

Nuclear Factor Of Activated T3 Is A Negative Regulator Of Ras-Jnk1/2-Ap-1 - Induced Cell Transformation

NFAT3, a substrate of JNKs, is a negative regulator of Ras-JNK-induced cell transformation

Mechanisms of Cytoplasmic β-Catenin Accumulation and Its Involvement in Tumorigenic Activities Mediated by Oncogenic Splicing Variant of the Receptor Originated from Nantes Tyrosine Kinase

Identification of a Human NF-κB-activating Protein, TAB3

PTPN3 Acts As a Tumor Suppressor and Boosts TGF-β Signaling Independent of Its Phosphatase Activity.

NF-κB is Required for H-ras Oncogene Induced Abnormal Cell Proliferation and Tumorigenesis

Cdk3-Mediated C-Jun Phosphorylation At Ser63 And Ser73 Enhances Cell Transformation

NRF-1 Directly Regulates TFE3 and Promotes the Proliferation of Renal Cancer Cells.

Data from Cyclin-Dependent Kinase-3–Mediated C-Jun Phosphorylation at Ser63 and Ser73 Enhances Cell Transformation

JNK-Dependent cJun Phosphorylation Mitigates TGFβ- and EGF-Induced Pre-Malignant Breast Cancer Cell Invasion by Suppressing AP-1-Mediated Transcriptional Responses.

NFAT3 is specifically required for TNF- -induced cyclooxygenase-2 (COX-2) expression and transformation of Cl41 cells

Ras-Dependent, Ca2+-Stimulated Activation Of Nuclear Factor Of Activated T Cells By A Constitutively Active Cbl Mutant In T Cells

TGF-β1 expression in regulatory NK1.1-CD4+NKG2D+ T cells dependents on the PI3K-p85α/JNK, NF-κB and STAT3 pathways

Regulation of the Orphan Receptor TR3 Nuclear Functions by C-Jun N Terminal Kinase Phosphorylation

Nuclear Factor of Activated T Cells in Cancer Development and Treatment.

TC21 Mediates Transformation and Cell Survival Via Activation of Phosphatidylinositol 3-Kinase/akt and NF-κB Signaling Pathway

Cooh-Terminal Src Kinase-Mediated C-Jun Phosphorylation Promotes C-Jun Degradation And Inhibits Cell Transformation

Identification of nerve growth factor-responsive element of the TCL1 promoter as a novel negative regulatory element

Jnk/Ap-1 Pathway is Involved in Tumor Necrosis Factor-Alpha Induced Expression of Vascular Endothelial Growth Factor in Mcf7 Cells

Nuclear protein IκB-ζ inhibits the activity of STAT3

A Requirement Of Stat3 Dna Binding Precludes Th-1 Immunostimulatory Gene Expression By Nf-Kappa B In Tumors